Itraconazole and rifampicin, as CYP3A modulators but not P-gp modulators, affect the pharmacokinetics of almonertinib and active metabolite HAS-719 in healthy volunteers

Lu Liu, Wěi Li, Le Yang, Zitao Guo, Hao Xue, Ningjie Xie, Xiaoyan Chen